Clinical Trials Browser

Phase 2 × Stomach Neoplasms × Gefitinib × Clear all

NCT03170180 2022-06-15

Exploratory Study of Drug Sensitivity Prediction Software (IRCR-DReSS) With Patient-derived Tumor Cells of Metastatic Gastric Cancer

Phase 2 Completed

Gastrointestinal

Stomach Neoplasms

NCT00215995 2012-01-13

Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas

Phase 2 Completed

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms